Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

5.32

+0.20 (3.91%)

At close: Sep 29, 2025, 4:00 PM EDT

5.32

0.00 (0.00%)

After-hours: Sep 29, 2025, 7:07 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
Genetic Therapies	2.98M	Log In
Genetic Therapies Growth	-42.74%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
United States	2.98M	Log In
United States Growth	-42.74%	Log In